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Nanosized particles of iron oxide (NPIO) has been applied extensively as contrast medium for magnetic resonance imaging (MRI).
Recently, micrometer sized particles of iron oxide (MPIO) has also been demonstrated the feasibility for cell labeling to monitor immune
response. In this study, we compared the cellular labeling efficiencies of these two kinds of magnetic particles. The NPIO exhibit stronger
saturation magnetization and produce more MRI signal change. On the contrary, MPIO revealed better particle uptake ability than
NPIO in incubated cells. Microscopically, both MPIO and NPIO were located in the cytoplasm but not in the cell nucleus. On MRI
examination, MPIO labeled cells showed more pronounced signal change compared to NPIO labeled cells. We conclude that MPIO is
more efficacious in cell labeling than NPIO. Further development and improvement of MPIO for its magnetization will facilitate its MRI
applications on stem cell trafficking, evaluation of transplantation rejection and monitoring immune responses.
Index Terms—Cell labeling, macrophage, magnetic materials, magnetic resonance imaging.
I. INTRODUCTION
MAGNETIC RESONANCE IMAGING (MRI) has beenused globally as a noninvasive tool for investigating
human anatomy and pathological conditions [1]. Iron oxide
based particle, as a biocompatible magnetic substance, is used
clinically as MRI contrast agent because it induces localized
magnetic field inhomogeneity, and causes regional signal
intensity decrease. Once it is delivered into human body,
macrophages of immune system will ingest these nanoparticles
and be labeled, so we can study their distribution by MRI [2].
This labeling technique can help physicians to differentiate
normal or diseased tissues.
Recently, micrometer sized magnetic iron oxide was evalu-
ated for its capability of cell labeling and visualizing in MRI
system [3]. Owing to its larger diameter, micrometer sized iron
oxide has stronger magnetism per particle compared to nano-
sized magnetic iron oxide [3]. But nanosized iron oxide posses
higher surface area, which is potentially beneficial for cell la-
beling. However, the study of comparison between MPIO and
NPIO about its cell labeling ability is very limited. In this study,
we used a commercial MPIO ferrofluid and a clinical approved
NPIO ferrofluid to investigate and compare their ability of cell
labeling. The commercial MPIO of product code #MC05F was
fabricated by the Bang’s laboratory, Fishers, IN, USA. The clin-
ical approved NPIO was supplied by Resovist, Schering AG,
Berlin, Germany. The physical and chemical properties of both
MPIO and NPIO magnetic fluids are compared in Table I ac-
cording to vendors’ brochure.
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TABLE I
PHYSICAL AND CHEMICAL PROPERTIES OF MPIO AND NPIO MAGNETIC
FLUIDS FROM VENDOR’S BROCHURE
II. EXPERIMENTAL PROCEDURES AND RESULTS
A. MRI and Magnetic Characteristics of MPIO and NPIO
To understand the inherent capability of signal generation in
MRI, the MR signals of both MPIO and NPIO were observed
under a 1.5 Tesla clinical MRI System (Signa Excite, GE
Healthcare NJ, USA). Both NPIO and MPIO were prepared
at the concentration of 1 mg Fe/ml and placed into a 1.5 ml
centrifuge tube. Then the test tubes were bathed in water
and scanned under T2 weighted gradient echo pulse sequences
resolution slice thickness mm, spacing
mm, ). A test tube filled with normal saline was
used as control sample. Compared to normal saline, the MRI
signal intensity of both NPIO and MPIO dropped. The NPIO
solutions exhibit more signal intensity drop than MPIO solu-
tions, which suggests the magnetization of NPIO is stronger
than MPIO. We also noticed MPIO tended to precipitate upon
exposure to high magnetic field. Consequently, there was
marked signal intensity drop at the bottom of the test tube
(Fig. 1).
In order to check the magnetic properties of both magnetic
fluids, magnetic hysteresis measurements at room tem-
perature were carried out by using a Quantum Design MPMS
SQUID magnetometer with the applied magnetic field up to 3 T.
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Fig. 1. Comparison of signal producing ability of MPIO and NPIO under 1.5 T
MRI. NPIO containing test tube exhibited marked signal intensity drop in the
whole test tube, while MPIO containing test tube just produced signal intensity
loss at the bottom of the test tube, where some of the MPIO is precipitated.
Fig. 2. Room temperature mass magnetization per FeM for MPIO and NPIO
magnetic fluids as a function of applied magnetic field. Low coercive field H
were found for both MPIO and NPIO particles. In addition, NPIO exhibits better
saturation magnetization than MPIO.
The mass magnetization per Fe for MPIO and NPIO mag-
netic particles are shown collectively in Fig. 2. Low coercive
field were found for both MPIO and NPIO particles. Larger
saturation magnetization of 80 emu/g per Fe was observed
for NPIO particles with the average diameter of 60 nm due
to near single-domain characteristics. This result indicates that
larger value corresponds to the signal intensity loss in MRI
data.
B. Efficiency of Cell Labeling
The cell labeling efficiency of MPIO and NPIO was deter-
mined by flow cytometry. We chose macrophage cell line Raw
264.7 as our testing target because it is a well accepted model
for evaluating particle uptake at the range from nanometer to mi-
crometer [4]. The cells were treated with either NPIO or MPIO
at the concentration of 0, 1, 10, or 100 g Fe/ml for 24 h, har-
vested, and evaluated under flow cytometry. Tens of thousands
of cells were scanned with laser beams and the intensity of cells’
side scattering (SSC) beams were recorded by photo multiplier
tube. Increased side scattering beam is regarded as increased
cellular granules. We found that there is increased granularity
in both NPIO and MPIO treated cells, which is evidenced by
right SSC shift of these measured cells. The right SSC shift of
the MPIO treated cells are more prominent than cells treated
with NPIO, which suggested the labeling efficiency of MPIO is
better. Both MPIO and NPIO treated cells showed dose response
manner in the aspect of increased cellular granularity (Fig. 3).
Fig. 3. Comparison of cellular granularity after MPIO or NPIO labeling by flow
cytometry. Macrophages were scanned by laser beams and the side scattering
of each cell was recorded and regarded as the index of cellular granularity. Both
MPIO and NPIO treated cells showed dose-responsive manner of increased cel-
lular granularity. Besides, the degree of granularity increase is more prominent
in MPIO treated cells. The finding suggests that MPIO is more efficient in cell
labeling, causing granularity increase in these cells.
For determination of exact location of MPIO and NPIO after
cell labeling, macrophages treated either with MPIO or NPIO
were visualized under light microscope (Nikon Eclipse TS100,
Tokyo, Japan) at the magnification of 200X before and after
Prussian blue staining, a method for staining ferric iron. Briefly,
cells were incubated with either NPIO or MPIO for 24 h at
the concentration of 10 g Fe/ml. Then these cells were fixed
with 10% formaldehyde and treated with 10% potassium ferro-
cyanide and 20% hydrochloric acid for 20 min. Then the cells
were washed and visualized under microscope.
Before staining, NPIO labeled cells showed shining gran-
ules inside the cytoplasm with sparing the cell nucleus, whereas
MPIO labeled cells revealed dark brown granules in the cyto-
plasm. After Prussian blue staining, both MPIO and NPIO la-
beled cells showed clusters of dense blue granules in the cy-
toplasm, which indicate the location of the iron oxide particles
(Fig. 4). We also noticed the staining degree differs in MPIO and
NPIO labeled cells. The NPIO was stained deeply whereas the
MPIO was stained lightly. The difference reflected the richness
of ferric iron in the different particles. The findings correlate
with the difference between saturation magnetization of MPIO
and NPIO. However, the amount of particles been labeled is hard
to count under microscopy.
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Fig. 4. Microscopic appearance of cells labeled with MPIO or NPIO. Com-
pared with nonlabeled cells (Panel A), NPIO labeled cells (Panel B) and MPIO
labeled cells (Panel C) showed shining granules in the cytoplasm, but not in the
cell nucleus. This finding was further confirmed by Prussian blue staining. The
cytoplasm of the NPIO (Panel E) and MPIO (Panel F) were stained blue whereas
the nonlabeled cells (Panel D) remained no color change after staining.
Fig. 5. MRI exam of MPIO and NPIO labeled cells. There is dose-response
manner of signal intensity drop in MPIO and NPIO labeled cells. Dark signal
change could be found at the bottom of the test tube even when cells were treated
with only 1 g Fe/ml of either MPIO or NPIO. The degree of signal intensity
change is more significant in cells labeled with MPIO. In addition to the flow
cytometry results, this findings further support the superior cell labeling ability
of MPIO toward NPIO.
C. MRI Characters of Labeled Cells
The labeling effect of MPIO and NPIO toward cells was con-
firmed by MRI. Macrophages exposed to 0, 1, 10, or 100 g
Fe/ml of MPIO or NPIO for 24 h were harvested and centrifuged
in a 1.5 ml tube. These cell samples were placed into 1.5 T clin-
ical MRI system and scanned under T2 weighted gradient echo
pulse sequences
resolution slice thickness
mm, spacing mm, ). Both MPIO and NPIO
labeled cells showed dose-response signal intensity drop under
T2 weighted pulse sequences. The signal change of MPIO la-
beled cells outperform those labeled with NPIO at the identical
iron concentration, which means MPIO is more efficacious in
cell labeling for MRI (Fig. 5).
III. DISCUSSION
Our results revealed labeling efficiency of MPIO is better
than NPIO in spite of lesser saturation magnetization observed
in MPIO. However, there is still some room for improvement
of MPIO. First, although MPIO could be dispersed easily, it
aggregates easily under strong magnetic fields. The character
is disadvantageous when it applies to clinical MRI, which
poses high magnetic fields. Aggregation of these particles will
potentially induce vascular thromboembolic events. Secondly,
we demonstrated that magnetic core of the MPIO is not opti-
mized, causing lower saturation magnetization and lower signal
intensity change compared to NPIO. Magnetic optimization of
MPIO will increase its detecting sensitivity and allow for easier
imaging of cells.
The application of cellular MRI has been investigated exten-
sively such as stem cells trafficking, imaging of macrophages re-
lated immune diseases [2]. However, the sensitivity of detecting
these cells is low. Besides, most of the labeling techniques are
based on NPIO magnetic materials. We believe that there will be
marked sensitivity change if MPIO could be optimized, which
will accelerate the clinical application of cellular MRI. Efforts
on the biocompatibility test of MPIO should also be carried out
shortly.
IV. CONCLUSION
MPIO is more efficacious in its labeling ability than NPIO
which is advantageous in its MRI application. Optimization of
the its magnetism and assurance of cell, tissue, and organ com-
patibility will facilitate its application to monitoring stem cell
transplantation, cellular immune response, and organ transplan-
tation rejection.
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